28.10.2011 • NewsCU Chemie Uetikon

Majority Stake in CU Chemie Uetikon Sold to Barclays Private Equity

Barclays Private Equity (BPE) has acquired a majority shareholding in CU Chemie Uetikon, a fine chemicals company based in Lahr, Germany.  With a shareholding of 90%, BPE will have a controlling interest in the spin-off from the Swiss group CPH Chemie + Papier Holding AG. Together with management, BPE said it will pursue a consistent growth strategy in pharmaceuticals, cosmetics and nutrition industries. The consideration is undisclosed and completion is subject to regulatory approval.

 

Company

CU Chemie Uetikon

Raiffeisenstr. 4
77933 Lahr
Germany

Company contact







Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.